These observed positive correlations between the GDF-15 levels and obesity/diabetes markers appear to be a compensatory response to the underlying pathological effects of the metabolic disruptions observed in obese and diabetic patients. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.